Dublin, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/xwfkd4/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering.
Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient's blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients. Since A1C test reflects the average amount of glucose for the past 2 to 3 months, it is opined to be more reliable than conventional blood glucose test.
Physicians are increasingly prescribing HbA1c test to their patients which will lead to an increase in the test volume. Moreover, rising diabetes incidence rate is a major driver for the HbA1c testing market. With growing awareness about prevention and management of diabetes, the demand for HbA1c testing devices will rise rapidly especially in the Asia-Pacific, Latin America, MiddleEast and African regions.
Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013and Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview
Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use
Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology
Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography
Chapter 7 Recommendations
Chapter 8 Company Profiles
- Chek Diagnostics
- Danaher Corporation
- EKF Diagnostics
- F. Hoffmann-La Roche
- Trinity Biotech
For more information visit http://www.researchandmarkets.com/research/xwfkd4/hemoglobin_a1c
CONTACT: Research and Markets Laura Wood, Senior Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Diagnostics
Source:Research and Markets